NCT03997669

Brief Summary

The diagnosis, treatment and mechanism of pleural diseases

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 25, 2019

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

November 16, 2021

Status Verified

November 1, 2021

Enrollment Period

7 months

First QC Date

January 22, 2019

Last Update Submit

November 15, 2021

Conditions

Pleural Diseases

Outcome Measures

Primary Outcomes (1)

  • overall survival

    the percentage of people in a group who are alive after a year for malignant pleural effusion

    1 years

Study Arms (2)

experimental group

patients with malignant pleural effusion

Other: Collection of pleural effusion

control group

patients with benign pleural effusion

Other: Collection of pleural effusion

Interventions

Collection of pleural effusionOTHER

Detection of pleural effusion

control groupexperimental group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with pleural effusion

You may qualify if:

  • Patients with pleural effusion, who has not been treated

You may not qualify if:

  • Patients with pleural effusion, who has already been treated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jinshuo Fan

Wuhan, State..., 430022, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

The blood and pleural effusions if there is any, will be collected and detected

MeSH Terms

Conditions

Pleural Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

  • Jinshuo Fan, MD

    Key Laboratory of Respiratory Diseases of the Ministry of Health

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 22, 2019

First Posted

June 25, 2019

Study Start

July 1, 2019

Primary Completion

February 1, 2020

Study Completion

October 1, 2021

Last Updated

November 16, 2021

Record last verified: 2021-11

Locations

CN(1)